The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

Visualising Psychotropic Medicine (VPM)

Presenting what can be a complex set of data in a useful and engaging way
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event BAP Session BAP Event BAP Stand

All Events

20th September 2018 Drug Treatments in Affective Disorders The International Centre For Life (Conferences), Times Square, Newcastle Upon Tyne
23rd September 2018 EUNETHYDIS International Conference on ADHD The Exchange, Edinburgh
1st October 2018 Immunopharmacology: Challenges, opportunities and research tools John McIntyre Conference Centre, University of Edinburgh

Clinical Certificate | Masterclasses | Non-Clinical Certificate

Articles

SYMPOSIUM 5: New concepts in the co-morbidity of psychiatric disorders, eating disorders and obesity.
By Sarah Stuart
Posted on 3rd August 2018

Underlying metabolic disturbances are often ignored when treating psychiatric disorders and can even be exacerbated with treatments, but it is becoming more apparent that these metabolic issues may not arise a result of treatment, but may instead be pre-existing in psychosis.  This session echoed the theme of schizophrenia and its co-morbidity with eating disorders that […]


SYMPOSIUM 3: Microglia role in neuropsychiatric disease and its potential as a treatment target
By Ciaran Fitzpatrick
Posted on 30th July 2018

(chaired by Valeria Mondelli & Peter Talbot)   Given that clinical, genetic and pharmacological findings indicate that inflammatory molecules and their associated pathways are enhanced in neuropsychiatric disorders such as major depressive disorder and schizophrenia, Monday morning’s symposium 3 dealt with the importance of microglia cells in these disorders. Microglia are immune...


Post-Doc Symposium 1: What can animal behaviours really tell us about human cognitive and emotional processes?
By Sarah Stuart
Posted on 30th July 2018

The amount of preclinical data being presented at the BAP Summer Meeting has been dwindling over the years, in favour of clinical and non-clinical human research.  This post-doctoral symposium was put together by myself and Dr Claire Hales from the University of Bristol to showcase preclinical work and to highlight the importance of using translational […]


See more articles

Media

Frank Tarazi
When words fail, music speaks: How music can help children with autism connect
Drs. Samata Sharma and Frank Tarazi from Harvard Medical School wrote an article for the World Economic Forum on the use of music as adjunctive therapy for children with autism
14th June 2018

Ed Bullmore
The Guardian: This revolution in our understanding of depression will be life-transforming
Ed wrote an article for The Guardian about the genetics of depression.
29th April 2018

Antonio Gonzalez
Improving opioid painkillers: can they be made safer?
Antonio (along with Sera Moore, Jade Morgan, and Joe Chadwick) was involved in the development of an informative video on novel, low-abuse analgesics and accompanying questionnaire.
13th April 2018

Sarah Bailey
The Guardian: Why science is being more open about animals in research
Sarah wrote an article for the Guardian about animal research and openness.
6th April 2018

Hip Hop Psych (Akeem Sule and Becky Inkster)
Analysing Stan: Psychologists reveal what Eminem's hit track really means
Akeem and Becky explain what Eminem’s ill-fated fictional superfan can tell us about the brain and mental health.
5th March 2018

See more media

News

Mental health in young people - Press Briefing
24th July 2018

Press coverage of the successful press briefing on 20th July on the importance of early intervention in mental illness in young people.
Read More
2018 Statistical Excellence in the Pharmaceutical Industry Award
18th July 2018

Simon Bate and Robin Clark win 2018 Statistical Excellence in the Pharmaceutical Industry Award for their development of InVivoStat
Read More
New Curriculum for Research Animals
13th June 2018

A new curriculum for University education in the use of research animals has just been launched.
Read More
Alzheimer’s researchers win world’s top brain research prize
6th March 2018

Four neuroscientists working in the UK, Belgium and Germany have today (6 March) won the world’s most valuable prize for brain research
Read More

See more news

Twitter


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.